Literature DB >> 30501952

Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.

Melanie P Subramanian1, Varun Puri2.   

Abstract

Entities:  

Year:  2018        PMID： 30501952      PMCID： PMC6486469          DOI： 10.1016/j.jtcvs.2018.10.062

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  8 in total

1.  Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.

Authors:  Yuzhao Wang; Jonathan C Yeung; Waël C Hanna; Frances Allison; Narinder S Paul; Thomas K Waddell; Marcelo Cypel; Marc E de Perrot; Kazuhiro Yasufuku; Shaf Keshavjee; Andrew F Pierre; Gail E Darling
Journal:  J Thorac Cardiovasc Surg       Date:  2018-10-06       Impact factor: 5.209

2.  Differences in patterns of recurrence in early-stage versus locally advanced non-small cell lung cancer.

Authors:  Feiran Lou; Camelia S Sima; Valerie W Rusch; David R Jones; James Huang
Journal:  Ann Thorac Surg       Date:  2014-08-07       Impact factor: 4.330

3.  Multiple primary lung cancers.

Authors:  N Martini; M R Melamed
Journal:  J Thorac Cardiovasc Surg       Date:  1975-10       Impact factor: 5.209

4.  Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.

Authors:  Christopher T Erb; Kevin W Su; Pamela R Soulos; Lynn T Tanoue; Cary P Gross
Journal:  Lung Cancer       Date:  2016-07-19       Impact factor: 5.705

5.  Second primary lung cancer.

Authors:  T Antakli; R F Schaefer; J E Rutherford; R C Read
Journal:  Ann Thorac Surg       Date:  1995-04       Impact factor: 4.330

Review 6.  Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis.

Authors:  Lynn Calman; Kinta Beaver; Daniel Hind; Paul Lorigan; Chris Roberts; Myfanwy Lloyd-Jones
Journal:  J Thorac Oncol       Date:  2011-12       Impact factor: 15.609

7.  Genomic heterogeneity of multiple synchronous lung cancer.

Authors:  Yu Liu; Jianjun Zhang; Lin Li; Guangliang Yin; Jianhua Zhang; Shan Zheng; Hannah Cheung; Ning Wu; Ning Lu; Xizeng Mao; Longhai Yang; Jiexin Zhang; Li Zhang; Sahil Seth; Huang Chen; Xingzhi Song; Kan Liu; Yongqiang Xie; Lina Zhou; Chuanduo Zhao; Naijun Han; Wenting Chen; Susu Zhang; Longyun Chen; Wenjun Cai; Lin Li; Miaozhong Shen; Ningzhi Xu; Shujun Cheng; Huanming Yang; J Jack Lee; Arlene Correa; Junya Fujimoto; Carmen Behrens; Chi-Wan Chow; William N William; John V Heymach; Waun Ki Hong; Stephen Swisher; Ignacio I Wistuba; Jun Wang; Dongmei Lin; Xiangyang Liu; P Andrew Futreal; Yanning Gao
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

8.  Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.

Authors:  Taichiro Goto; Yosuke Hirotsu; Hitoshi Mochizuki; Takahiro Nakagomi; Daichi Shikata; Yujiro Yokoyama; Toshio Oyama; Kenji Amemiya; Kenichiro Okimoto; Masao Omata
Journal:  Oncotarget       Date:  2017-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.